855860-75-2 Usage
Uses
Used in Pharmaceutical Industry:
N-(4-aminophenyl)-2-chloro-N-methylacetamide is utilized as an intermediate in the synthesis of various pharmaceuticals and organic compounds. Its unique structure and functional groups contribute to the development of new drugs with potential therapeutic benefits.
Used in Antimicrobial Applications:
Due to its antimicrobial properties, N-(4-aminophenyl)-2-chloro-N-methylacetamide is employed as an antimicrobial agent. It can be used to combat a range of microorganisms, thereby serving as a potential component in the formulation of antimicrobial products.
Used in Anti-inflammatory Applications:
Leveraging its anti-inflammatory properties, N-(4-aminophenyl)-2-chloro-N-methylacetamide is used in the development of anti-inflammatory drugs. This application can aid in the management of conditions characterized by inflammation, offering a new avenue for treatment options.
It is crucial to handle N-(4-aminophenyl)-2-chloro-N-methylacetamide with care, adhering to recommended safety guidelines to mitigate any potential health hazards associated with its use.
Check Digit Verification of cas no
The CAS Registry Mumber 855860-75-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,5,8,6 and 0 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 855860-75:
(8*8)+(7*5)+(6*5)+(5*8)+(4*6)+(3*0)+(2*7)+(1*5)=212
212 % 10 = 2
So 855860-75-2 is a valid CAS Registry Number.
855860-75-2Relevant academic research and scientific papers
An improved process for the synthesis of nintedanib esylate
Arava, Veerareddy,Gogireddy, Surendrareddy
supporting information, p. 975 - 981 (2017/05/04)
Nintedanib esylate is synthesized via novel intermediates of (Z)-methyl 3-(acetoxy-phenyl)methylene)-1-acetyl-2-oxoindoline-6-carboxylate and N-(4-aminophenyl)-2-chloro-N-methylacetamide in good yields.
PROLINYLARYLACETAMIDES
-
Page/Page column 41, (2010/02/12)
Novel compounds of formula (I) wherein R, R1, R2, R3, X, X', and Y have the meaning cited in Claim 1. Said compounds are inhibitors of coagulation factor Xa and can be used for the prophylaxis and/or therapy of thromboembolic diseases and in the treatment of tumours.
